Agomab Therapeutics NV (AGMB) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-10 | 6-K | FORM 6-K | SEC |
| 2026-08-06 | 6-K | — | SEC |
| 2026-06-23 | 6-K | FORM 6-K | SEC |
| 2026-05-27 | 6-K | FORM 6-K | SEC |
| 2026-04-24 | 6-K | FORM 6-K | SEC |
| 2026-03-05 | 6-K | FORM 6-K | SEC |
| 2026-02-09 | 6-K | FORM 6-K | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.